Apellis Pharmaceuticals, Inc. (APLS)

Apellis Pharmaceuticals Stock Forecast

Stock Price Forecast

The 19 analysts that cover Apellis Pharmaceuticals stock have a consensus rating of "Buy" and an average price target of $32.16, which forecasts a 37.03% increase in the stock price over the next year. The lowest target is $18 and the highest is $52.

Price Target: $32.16 (+37.03%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$18	$32.16	$28	$52
Change	-23.31%	+37.03%	+19.30%	+121.56%

Analyst Ratings

The average analyst rating for Apellis Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26
Strong Buy	3	4	4	5	6	6
Buy	7	7	7	6	5	5
Hold	9	8	9	8	8	8
Sell	0	0	0	0	0	0
Strong Sell	1	1	1	1	1	1
Total	20	20	21	20	20	20

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Eliana Merle Barclays	Barclays	Hold Initiates $24	Hold	Initiates	$24	+2.26%	Jan 28, 2026
Tazeen Ahmad B of A Securities	B of A Securities	Hold → Strong Buy Upgrades $28	Hold → Strong Buy	Upgrades	$28	+19.30%	Jan 21, 2026
Derek Archila Wells Fargo	Wells Fargo	Buy Maintains $29 → $26	Buy	Maintains	$29 → $26	+10.78%	Jan 20, 2026
Steve Seedhouse Cantor Fitzgerald	Cantor Fitzgerald	Buy Maintains $39 → $35	Buy	Maintains	$39 → $35	+49.13%	Jan 13, 2026
Joseph Stringer Needham	Needham	Strong Buy Maintains $29 → $28	Strong Buy	Maintains	$29 → $28	+19.30%	Jan 13, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

1.03B

Increased by 31.31%

from 781.37M

Revenue Next Year

883.75M

Decreased by -13.86%

from 1.03B

EPS This Year

0.22

from -1.60

EPS Next Year

-1.15

from 0.22

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	250.65M	66.56M	75.42M	396.59M	781.37M	1.03B	883.75M
Revenue Growth	-	-73.44%	13.31%	425.83%	97.02%	31.31%	-13.86%
EPS	-4.59	-8.84	-6.15	-4.45	-1.60	0.22	-1.15
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	106.83	-
No. Analysts	-	-	-	-	-	22	22

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	1.1B	1.0B
Avg	1.0B	883.8M
Low	974.1M	768.0M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	41.2%	-2.2%
Avg	31.3%	-13.9%
Low	24.7%	-25.1%

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	0.34	0.44
Avg	0.22	-1.15
Low	0.18	-1.84

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	-	101.7%
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.